Rapid and reliable detection of cryptococcal infection

The IMMY CrAg LFA (cryptococcal antigen lateral flow assay) is the first immunochromatographic dipstick assay for the qualitative and semiquantitative detection of the cryptococcal capsular antigen in serum, plasma and cerebrospinal fluid (CSF). Available exclusively in the UK from Alpha Laboratories, it has revolutionised cryptococcal antigen testing, with excellent sensitivity across all serotypes of Cryptococcus. CrAg LFA can detect all four CrAg serotypes, with improved sensitivity for Cryptococcus gattii infections (serotype C).

The test involves five easy steps with no equipment required and no specimen pretreatment. It takes just 10 minutes with less than a minute of hands-on time. The CrAg LFA is easily scaled up to handle multiple samples. It allows for titre determination (semiquantitation) with up to five times greater sensitivity than other cryptococcal antigen tests on the market.

Cryptococcosis, a fungal disease caused by Cryptococcus species complex (C. neoformans [pictured in lung stained with mucicarmine] and C. gattii), is one of the most common HIV-related opportunistic infections. Each year, approximately 1,000,000 cases of cryptococcal meningitis occur globally, resulting in more than 1700 deaths every day. Patients undergoing organ transplantation or aggressive treatment of cancer and connective tissue diseases are also at risk of developing the disease due to immunosuppression.

www.alphalabs.co.uk/crag

 

Other news

Upcoming Events

Biosafety Practitioner Level 1 Training Course

Public Health England
15-19 January 2018

British Society for Microbial Technology Annual Scientific Conference

Public Health England, Colindale, London
18 May 2018

Pathology Horizons 2018 Conference

Lough Erne Resort, Co. Fermanagh, Northern Ireland
September 13-15

Microbe 2018

Hilton Hotel, Sheffield
21-23 September 2018

Latest Issue

Pathology In Practice

Pathology In Practice

Aug 2017

Screening for haemoglobinopathies

Register now to apply for regular copies of Pathology In Practice and free access to premium content, as well as our regular newsletters.